Next PLC
15 December 2004
Next plc
Off-market purchases by way of contingent purchase contract by the Company of
ordinary shares for cancellation
Next plc announces that, pursuant to the contingent forward purchase contract it
entered into with Goldman Sachs International on 1 December 2004, it has today
purchased 50,000 ordinary shares for cancellation at a price of 1575 pence per
share.
A J R McKinlay
Company Secretary
Next plc
Editorial note:
Under the contingent contract, the Company may purchase a fixed number of shares
each week (other than in the weeks ending 22 and 29 December 2004), in the
period to 29 June 2005, at a fixed price that is at a discount to the market
price prevailing at the start of the contract period. The contract is contingent
in that it would terminate early, and no further shares would be purchased, if
the Company's share price increases to a pre-determined suspension level during
the contract period. This suspension level has been set at the start of the
contract and is between 104% and 110% of the Company's share price at the start
of the contract.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.